MX394013B - Proceso industrial para la preparación de cariprazina. - Google Patents

Proceso industrial para la preparación de cariprazina.

Info

Publication number
MX394013B
MX394013B MX2021012390A MX2021012390A MX394013B MX 394013 B MX394013 B MX 394013B MX 2021012390 A MX2021012390 A MX 2021012390A MX 2021012390 A MX2021012390 A MX 2021012390A MX 394013 B MX394013 B MX 394013B
Authority
MX
Mexico
Prior art keywords
trans
cariprazine
cyclohexyl
acetic acid
dichlorophenyl
Prior art date
Application number
MX2021012390A
Other languages
English (en)
Other versions
MX2021012390A (es
Inventor
József Neu
Sándor Garadnay
Tamás Szabó
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of MX2021012390A publication Critical patent/MX2021012390A/es
Publication of MX394013B publication Critical patent/MX394013B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/26Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

En el proceso de la presente invención, la cariprazina se prepara convirtiendo el clorhidrato de éster etílico del ácido (trans-4-amino-ciclohexil)-acético a ácido (trans-4-aminociclohexil) acético o su clorhidrato por hidrólisis, a partir del producto obtenido con la adición de derivado de dimetilcarbamoílo como un reactivo adecuado se forma ácido (trans-4-{[(dimetilamino)carbonil]amino}ciclohexil) acético, luego el compuesto obtenido se une a 1-{2,3-diclorofenil)~piperazina en presencia de reactivo de acoplamiento activador de ácido carboxílico, y así se forma 1,1-dimetil-3-[trans-4-(2-oxo-2-(4-(2,3-diclorofenil)piperazin-1-il-etil)ciclohexil] urea, que se convierte en aducto de borano cariprazina de fórmula (2) en presencia de un agente reductor, y finalmente el producto en sí mismo es eliminado directamente o se obtiene a partir de su sal mediante un método conocido. La invención también se refiere a un grupo de compuestos intermedios que se forman y/o se usan en el proceso de acuerdo con la presente invención.
MX2021012390A 2016-07-08 2017-07-07 Proceso industrial para la preparación de cariprazina. MX394013B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HUP1600420 2016-07-08
HU1700197A HU231173B1 (hu) 2016-07-08 2017-05-09 Ipari eljárás cariprazine előállítására
PCT/IB2017/054094 WO2018007986A1 (en) 2016-07-08 2017-07-07 Industrial process for the preparation of cariprazine

Publications (2)

Publication Number Publication Date
MX2021012390A MX2021012390A (es) 2022-07-18
MX394013B true MX394013B (es) 2025-03-24

Family

ID=89992438

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2021012390A MX394013B (es) 2016-07-08 2017-07-07 Proceso industrial para la preparación de cariprazina.
MX2019000330A MX388581B (es) 2016-07-08 2017-07-07 Proceso industrial para la preparacion de cariprazina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2019000330A MX388581B (es) 2016-07-08 2017-07-07 Proceso industrial para la preparacion de cariprazina.

Country Status (22)

Country Link
EP (2) EP3481811B1 (es)
JP (1) JP7065824B2 (es)
CN (1) CN109476617B (es)
AU (1) AU2017292177B2 (es)
CA (1) CA3030102A1 (es)
CY (1) CY1125548T1 (es)
DK (1) DK3481811T3 (es)
EA (1) EA036312B1 (es)
ES (1) ES2924995T3 (es)
GE (1) GEP20217217B (es)
HR (1) HRP20221037T1 (es)
HU (2) HU231173B1 (es)
IL (1) IL264074B (es)
LT (1) LT3481811T (es)
MX (2) MX394013B (es)
PL (1) PL3481811T3 (es)
PT (1) PT3481811T (es)
RS (1) RS63480B1 (es)
SG (1) SG11201811291QA (es)
SI (1) SI3481811T1 (es)
UA (1) UA123797C2 (es)
WO (1) WO2018007986A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110240548A (zh) * 2018-03-09 2019-09-17 上虞京新药业有限公司 一种卡利拉嗪中间体的制备方法
CN110317182B (zh) * 2018-03-29 2021-10-15 上虞京新药业有限公司 一种卡利拉嗪的制备方法
CN108586389B (zh) * 2018-06-29 2020-06-12 成都福柯斯医药技术有限公司 一种合成卡利拉嗪的方法
WO2020056929A1 (zh) * 2018-09-21 2020-03-26 上海诚妙医药科技有限公司 卡利拉嗪盐酸盐的新晶型及其制备方法及其用途
CN114539185B (zh) * 2020-11-24 2024-12-24 上海新礼泰药业有限公司 一种卡利拉嗪及其中间体的制备方法
HUP2100108A1 (hu) 2021-03-12 2022-09-28 Richter Gedeon Nyrt Eljárás és berendezés gyógyászatilag alkalmazható piperazin származékok folyamatos áramú, áramlásos konszekutív redukálással történõ elõállítására
CN115806510B (zh) * 2023-02-03 2023-04-21 成都福柯斯医药技术有限公司 3-反式-4-(2-羟乙基)环己基-1,1-二甲基脲的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010009912A1 (en) 1995-02-10 2001-07-26 Christos Tsaklakidis New derivatives of pyridil piperazine or pyridazinyl piperazyl, process for production thereof and medicaments containing these compounds
HU227543B1 (en) * 2001-09-28 2011-08-29 Richter Gedeon Nyrt N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them
HU227534B1 (en) * 2003-08-04 2011-08-29 Richter Gedeon Nyrt (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them
AR052019A1 (es) 2004-10-15 2007-02-28 Bayer Pharmaceuticals Corp COMPUESTOS HETEROCICLICOS, PROCESOS DE PREPARACIoN Y MÉTODO PARA TRATAR ENFERMEDADES HIPERPROLIFERATIVAS
HU229858B1 (en) * 2008-12-17 2014-10-28 Richter Gedeon Nyrt Process for the preparation of trans 4-amino-cyclohexyl acetic acid ethyl ester hcl
HU230067B1 (hu) 2008-12-17 2015-06-29 Richter Gedeon Nyrt Új piperazin só és eljárás előállítására
US8912197B2 (en) * 2012-08-20 2014-12-16 Forest Laboratories Holdings Ltd. Crystalline form of carbamoyl-cyclohexane derivatives
HU231227B1 (hu) * 2012-11-29 2022-03-28 Richter Gedeon Nyrt. Transz-4-{2-[4-(2,3-diklórfenil)-piperazin-1-il]-etil}N,N-dimetilkarbamoil-ciklohexilamin skizofrénia negatív tüneteinek kezelésére
ITMI20131693A1 (it) 2013-10-14 2015-04-15 Chemo Res S L Derivati della 1,4-cicloesilammina e loro preparazione
CN105218484B (zh) * 2015-09-14 2018-02-23 安徽省逸欣铭医药科技有限公司 酒石酸卡利拉嗪及其制备方法和医药用途
CN105330616B (zh) * 2015-12-09 2017-09-26 苏州明锐医药科技有限公司 卡利拉嗪的制备方法

Also Published As

Publication number Publication date
IL264074A (en) 2019-01-31
AU2017292177B2 (en) 2021-07-29
CN109476617B (zh) 2023-04-04
HUP1700197A2 (en) 2018-09-28
MX2019000330A (es) 2019-05-20
LT3481811T (lt) 2022-08-25
HU231173B1 (hu) 2021-06-28
BR112018077305A2 (pt) 2019-04-02
EP4043446A3 (en) 2023-01-18
RS63480B1 (sr) 2022-08-31
SG11201811291QA (en) 2019-01-30
ES2924995T3 (es) 2022-10-13
HRP20221037T1 (hr) 2022-11-11
CA3030102A1 (en) 2018-01-11
IL264074B (en) 2021-10-31
JP7065824B2 (ja) 2022-05-12
JP2019527210A (ja) 2019-09-26
CY1125548T1 (el) 2026-02-25
CN109476617A (zh) 2019-03-15
MX388581B (es) 2025-03-19
EP3481811B1 (en) 2022-05-25
HUE059285T2 (hu) 2022-11-28
EP4043446A2 (en) 2022-08-17
DK3481811T3 (da) 2022-09-05
AU2017292177A1 (en) 2019-02-07
GEP20217217B (en) 2021-02-10
SI3481811T1 (sl) 2022-10-28
UA123797C2 (uk) 2021-06-02
EP3481811A1 (en) 2019-05-15
PL3481811T3 (pl) 2022-09-12
WO2018007986A1 (en) 2018-01-11
EA036312B1 (ru) 2020-10-26
PT3481811T (pt) 2022-08-23
MX2021012390A (es) 2022-07-18
EA201990097A1 (ru) 2019-06-28

Similar Documents

Publication Publication Date Title
MX394013B (es) Proceso industrial para la preparación de cariprazina.
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
ATE549321T1 (de) Verfahren zur herstellung von phenylalaninderivaten mit chinazolindiongerüsten, und zwischenprodukte für die herstellung
WO2020016749A3 (en) Chemical process for preparing phenylpiperidinyl indole derivatives
AU2016237099B2 (en) Method for producing novel nitrogen-containing compound or salt thereof, and production intermediate of same
MX2009003853A (es) Metodo para producir amidas terciarias de acidos alquilfenilcarboxilicos.
PH12015501226A1 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing the same
MX352470B (es) Disales de acido malonico y metodo para preparar dihaluros de malonilo.
BR112014018756A8 (pt) Processo para preparo de etil éster de ácido n-(4-ciclo-hexil-3-trifluorometil-benziloxi)-acetimídico
WO2012099734A3 (en) Improved process for preparation of low molecular weight molybdenum succinimide complexes
MX353863B (es) Metodo para preparar una forma solida de acido acetico y productos de la misma.
WO2012099736A3 (en) Improved process for preparation of high molecular weight molybdenum succinimide complexes
FR2972452B1 (fr) Procede de preparation du difluoroacetonitrile et de ses derives
JO2928B1 (en) Method of synthesis of ferroquine by convergent reductive amination
ATE532516T1 (de) Verfahren zur synthese von glyt-1-hemmern
IN2014CN02346A (es)
MX353203B (es) Metodo para producir un derivado heterociclico fenilo sustituido por medio del metodo de acoplamiento utilizando un compuesto paladio.
FR2976940B1 (fr) Procede de preparation d'acide alpha- et beta-aminophosphores et leurs derives
ATE441627T1 (de) Verfahren zur herstellung von valsartan
PH12018500677B1 (en) Method for producing optically active 2- (2-fluorobiphenyl-4-yl) propanoic acid
MX2014013761A (es) Acidos (3r,4r,5s)-5-guanidino-4-acetamido-3-(pentan-3-iloxi)cicloh exen-1-carboxilicos fluorosustituidos, sus esteres y uso de los mismos.
EA033071B1 (ru) Способ увеличения выхода продуктов из ацетолактата
MY168411A (en) Method for preparing compound by novel michael addition reaction using water or various acids as additive
BR112018007505A2 (pt) processo industrial para a preparação de sal de (e)-3-carboxiacrilato de (5s,10s)-10-benzil-16-metil-11,14,18-trioxo-15,17,19-trioxa-2,7,8-tritia-12-aza-henicosan-5-amínio
ATE427297T1 (de) Verfahren zur herstellung von beta- aminopropionsaurederivaten